Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia (CROSBI ID 302070)

Prilog u časopisu | ostalo | međunarodna recenzija

Milicevic, Z. ; Raz, I. ; Beattie, S. D. ; Campaigne, B. N. ; Sarwat, S. ; Gromniak, E. ; Kowalska, I. ; Galic, E. ; Tan, M. ; Hanefeld, M. Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia // Diabetes care, 31 (2008), Supplement 2; S155-S160. doi: 10.2337/dc08-s240

Podaci o odgovornosti

Milicevic, Z. ; Raz, I. ; Beattie, S. D. ; Campaigne, B. N. ; Sarwat, S. ; Gromniak, E. ; Kowalska, I. ; Galic, E. ; Tan, M. ; Hanefeld, M.

engleski

Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia

Atherosclerotic vascular disease is more common in diabetic than in nondiabetic individuals. Diabetic macrovascular disease also has a more severe course with greater prevalence of multiplevessel coronary artery disease and more diffuse elongated atheromas in affected blood vessels. In this review, we discuss possible reasons for increased incidence of cardiovascular (CV) events in individuals with diabetes. Although an increased prevalence of standard CV risk factors has been clearly documented in association with diabetes, diabetes-related abnormalities, particularly hyperglycemia, also play an important role. Epidemiological studies suggest that the effect of hyperglycemia on CV risk is independent of other known risk factors, but no data from primary interventional trials are available yet. Analysis of datasets from populations that included individuals with impaired glucose tolerance and impaired fasting glucose suggest that the pathogenic role of hyperglycemia on the blood vessel wall already exists in the early stages of glucose intolerance. The effect of postprandial or postchallenge hyperglycemia seems to be greater than the effect of fasting blood glucose abnormalities. The relationship of postprandial glycemia, fasting blood glucose, and CV risk in individuals with diagnosed (or overt) diabetes is less clear, although most reports indicate a greater pathogenic potential of postprandial hyperglycemia rather than fasting hyperglycemia. Based on the results of epidemiological reports, the most appropriate targets in interventional trials are postprandial hyperglycemia or A1C.

Cardiovascular Disease, Diabetes

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

31 (Supplement 2)

2008.

S155-S160

objavljeno

0149-5992

10.2337/dc08-s240

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost